IMPROVED IRON CHELATION WITH DEFERASIROX AND ZINC COMBINATIONAL THREAPY IN PATIENTS WITH BETA THALASSEMIA MAJOR: IS IT ADDITIVE OR SYNERGISTIC?

被引：0
|
作者：
Unal, S. [1 ]
Celik, T. [2 ]
Ozer, C. [2 ]
Ilhan, G. [1 ]
Oktay, G. [1 ]
机构：
[1] Antakya State Hosp, Antakya, Turkey
[2] Mustafa Kemal Univ, Antakya, Turkey
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0930
引用
收藏
页码：385 / 385
页数：1
相关论文
共 50 条
  • [21] Zinc Status in Beta Thalassemia Major Patients
    Karunara, Attanayaka Mudiyanselage Dilhara Sewwandi
    Ranasingha, Jamburagoda Gamage Shirani
    Mudiyanse, Rasnayaka Mudiyanselage
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2018, 184 (01) : 1 - 6
  • [22] Zinc Status in Beta Thalassemia Major Patients
    Attanayaka Mudiyanselage Dilhara Sewwandi Karunaratna
    Jamburagoda Gamage Shirani Ranasingha
    Rasnayaka Mudiyanselage Mudiyanse
    Biological Trace Element Research, 2018, 184 : 1 - 6
  • [23] Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up
    Cappellini, M. Domenica
    Bejaoui, Mohamed
    Agaoglu, Leyla
    Canatan, Duran
    Capra, Marcello
    Cohen, Alan
    Drelichman, Guillermo
    Economou, Marina
    Fattoum, Slaheddine
    Kattamis, Antonis
    Kilinc, Yurdanur
    Perrotta, Silverio
    Piga, Antonio
    Porter, John B.
    Griffel, Louis
    Dong, Victor
    Clark, Joan
    Aydinok, Yesim
    BLOOD, 2011, 118 (04) : 884 - 893
  • [24] NONCOMPLIANCE WITH IRON CHELATION-THERAPY IN PATIENTS WITH BETA THALASSEMIA
    BERATIS, S
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 1989, 33 (06) : 739 - 745
  • [25] A decisional algorithm to start iron chelation in patients with beta thalassemia
    Danjou, Fabrice
    Cabantchik, Zvi Ioav
    Origa, Raffaella
    Moi, Paolo
    Marcias, Michela
    Barella, Susanna
    Defraia, Elisabetta
    Dessi, Carlo
    Foschini, Maria Loreta
    Giagu, Nicolina
    Leoni, Giovan Battista
    Morittu, Maddalena
    Galanello, Renzo
    HAEMATOLOGICA, 2014, 99 (03) : E38 - E40
  • [26] COMBINATION OF DEFERASIROX AND DEFEROXAMINE IN CLINICAL PRACTICE: ALTERNATIVE SCHEMES OF CHELATION IN THALASSEMIA MAJOR (TM) PATIENTS
    Cassinerio, E.
    Zanaboni, L.
    Roghi, A.
    Poggiali, E.
    Gandolfi, I.
    Mazzoleni, M.
    Duca, L.
    Orofino, N.
    Cappellini, M.
    HAEMATOLOGICA, 2013, 98 : 701 - 702
  • [27] Effects of dual chelation therapy with deferasirox and deferoxamine in patients with beta thalassaemia major
    Zargari, Ahmad
    Wu, Simon
    Greenway, Anthea
    Cheng, Ken
    Kaplan, Zane
    VOX SANGUINIS, 2022, 117 (05) : 733 - 737
  • [28] Adherence to Iron Chelation Therapy with Deferasirox Formulations among Patients with Sickle Cell Disease and β-thalassemia
    Oyedeji, Charity, I
    Crawford, Regina D.
    Shah, Nirmish
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2021, 113 (02) : 170 - 176
  • [29] Paradoxically Increased Ferritin Level in a Beta-Thalassemia Major Patient following the Start of Deferasirox Chelation Therapy
    Ricchi, Paolo
    Ammirabile, Massimiliano
    Spasiano, Anna
    Costantini, Silvia
    Cinque, Patrizia
    Di Matola, Tiziana
    Prossomariti, Luciano
    ACTA HAEMATOLOGICA, 2010, 123 (02) : 117 - 120
  • [30] Deferasirox-Iron Complex Formation Ratio as an Indicator of Long-term Chelation Efficacy in β-Thalassemia Major
    Lu, Meng-Yao
    Lin, Ting-Hao
    Chiang, Po-Hung
    Kuo, Pei-Hsin
    Wang, Ning
    Wu, Wen-Hsin
    Lin, Kai-Hsin
    Wu, Tzu-Hua
    THERAPEUTIC DRUG MONITORING, 2017, 39 (02) : 185 - 191
12345